Search Within

Dmitriy Zamarin

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (28)
  2. Meeting Abstract (23)
  3. Book Section (1)
  4. Guidelines (1)
Groups
  1. Department of Medicine (53)
  2. GDMT, Medicine (53)
  3. Gynecologic Medicine Service (53)
  4. Gynecology Disease Management Team (53)
  5. Hematologic Malignancies, Division of (53)
  6. Solid Tumor Oncology Division (53)

More Groups

People
  1. Roisin O'Cearbhaill (42)
  2. Carol Aghajanian (39)
  3. Rachel Grisham (23)
  4. Alexia Iasonos (22)
  5. Claire Friedman (21)
  6. Jason Konner (21)

More People

Years
  1. 2024 (3)
  2. 2023 (6)
  3. 2022 (9)
  4. 2021 (4)
  5. 2020 (9)
  6. 2019 (7)

More Years

Publications
  1. Gynecologic Oncology (16)
  2. Journal of Clinical Oncology (13)
  3. Clinical Cancer Research (3)
  4. International Journal of Gynecological Cancer (3)
  5. Blood (2)
  6. Cell (2)

More Publications

Publishers
  1. Elsevier Inc. (17)
  2. American Society of Clinical Oncology (15)
  3. American Association for Cancer Research (4)
  4. Lippincott Williams & Wilkins (4)
  5. Nature Publishing Group (3)
  6. American Society of Hematology (2)

More Publishers

Results (53)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase Ib study of miransertib (ARQ 092) in combination with anastrozole in patients with PIK3CA or AKT1-mutant ER+ endometrial or ovarian cancer
    Meeting Abstract

    Hyman, D.; Bonafede, M.; O'Cearbhaill, R.; Grisham, R.; Zamarin, D.; Tew, W.; Aghajanian, C.; Cadoo, K.; Friedman, C.; Savage, R. E.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Clinical utility of prospective molecular characterization in advanced endometrial cancer
    Journal Article

    Soumerai, T. E.; Donoghue, M. T. A.; Bandlamudi, C.; Srinivasan, P.; Chang, M. T.; Zamarin, D.; Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Tew, W. P.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of intraperitoneal (IP) cisplatin, IV/IP paclitaxel, IV bevacizumab, and oral olaparib for newly diagnosed adenxal carcinoma
    Meeting Abstract

    Konner, J. A.; Boucicaut, N. N.; O'Cearbhaill, R. E.; Zamarin, D.; Makker, V.; Sabbatini, P.; Tew, W. P.; Cadoo, K. A.; Grisham, R. N.; Aghajanian, C.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Somatic mutations in homologous recombination pathway genes in ovarian cancer
    Meeting Abstract

    Aghajanian, C.; DeLair, D.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Makker, V.; O'Cearbhaill, R. E.; Sabbatini, P.; Soumerai, T.; Charen, A. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: A Surveillance, Epidemiology, and End Results cohort study, 2000-2013
    Journal Article

    Oseledchyk, A.; Leitao, M. M. Jr; Konner, J.; O'Cearbhaill, R. E.; Zamarin, D.; Sonoda, Y.; Gardner, G. J.; Roche, K. L.; Aghajanian, C. A.; Grisham, R. N.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
    Journal Article

    Holmgaard, R. B.; Zamarin, D.; Lesokhin, A.; Merghoub, T.; Wolchok, J. D.
    EBioMedicine (2016)

    Fulltext@MSK | Save
  • Harnessing the immune system for cancer therapy
    Journal Article

    Smith, E. L.; Zamarin, D.; Lesokhin, A. M.
    Current Opinion in Oncology (2014)

    Fulltext@MSK | Save
  • Cancer immunology
    Book Section

    Hobbs, G.; Lesokhin, A. M.; Zamarin, D.; Wolchok, J. D.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: Incidence and prognostic significance
    Journal Article

    Zamarin, D.; Devlin, S. M.; Arcila, M. E.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Chimento, D.; Weltz, J.; Babu, D.; more...
    Leukemia (2013)

    Fulltext@MSK | Save